- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
7. The following table sets out the fees relating to a pharmaceutical veterinary medicinal product for—
(a)a national application for a marketing authorisation that is—
(i)a full application under Part 1 of Schedule 1;
(ii)a bibliographic application; or
(iii)an application based on pharmacological equivalence;
(b)an application for a marketing authorisation using the decentralised procedure where the United Kingdom is a concerned member State;
(c)an application for the mutual recognition of a product authorised in another member State.
Pharmacologically Equivalent national application | |||||
---|---|---|---|---|---|
Menu | Full national application under Part 1 of Schedule 1 (£) | Bibliographic national application (£) | Reference product authorised in UK (£) | Reference product not authorised in UK (£) | Decentralised application where the UK is a concerned member State or recognition of a product authorised in another member State (£) |
Base Fee: | 930 | 1,860 | 1,860 | 2,380 | 460 |
The following fees are in addition to the base fee: | |||||
Quality assessment (if quality data are assessed): | 3,900 | 3,320 | 2,790 | 3,560 | 1,860 |
Safety assessment (if safety data are assessed): | 3,900 | 3,120 | 1,060 | 1,360 | 1,860 |
Efficacy assessment (if efficacy data are assessed): | 3,900 | 3,120 | 1,060 | 1,360 | 1,860 |
Ecotoxicology assessment:(if ecotoxicology data are assessed): | 660 | 530 | 330 | 420 | 400 |
Additional fee if any of the target species is a food-producing animal (not payable if neither safety data nor ecotoxicology data are assessed): | 3,850 | 3,520 | 2,120 | 2,710 | 1,390 |
Reduced by— if no safety data are assessed: | 2,160 | 2,160 | 1,320 | 1,690 | 660 |
if no ecotoxicology data are assessed: | 1,020 | 780 | 300 | 380 | 300 |
Additional fee for each active ingredient not previously included in a veterinary medicinal product authorised in the United Kingdom— | |||||
food-producing animal: | 7,350 | 6,500 | 5,770 | 7,370 | 2,590 |
non-food-producing animal: | 6,430 | 5,770 | 5,510 | 7,030 | 2,260 |
Additional fee for each additional pack type: | 730 | 730 | 600 | 760 | 330 |
Reduced by— if no quality data are assessed: | 360 | 360 | 360 | 460 | 120 |
if no safety data are assessed: | 180 | 180 | 120 | 150 | 60 |
if no efficacy data are assessed: | 60 | 60 | 60 | 80 | 60 |
if no ecotoxicity data are assessed: | 60 | 60 | – | – | 60 |
Additional fee for each additional active ingredient(food-producing animal): | 6,360 | 6,030 | 3,980 | 5,090 | 2,060 |
Reduced by— if no quality data are assessed: | 1,440 | 1,440 | 1,440 | 1,840 | 480 |
if no safety data are assessed: | 2,690 | 2,690 | 1,620 | 2,070 | 840 |
if no efficacy data are assessed: | 900 | 720 | 540 | 690 | 300 |
if no ecotoxicity data are assessed: | 720 | 600 | – | – | 240 |
Additional fee for each additional active ingredient(non-food-producing animal): | 4,250 | 4,050 | 3,180 | 4,070 | 1,460 |
Reduced by— if no quality data are assessed: | 1,440 | 1,440 | 1,440 | 1,840 | 480 |
if no safety data are assessed: | 1,440 | 1,440 | 900 | 1,150 | 480 |
if no efficacy data are assessed: | 900 | 720 | 540 | 690 | 300 |
if no ecotoxicity data are assessed: | 60 | 60 | – | – | 60 |
Additional fee if there is more than one target species, for each additional species (food-producing animal): | 3,910 | 3,520 | 2,390 | 3,050 | 1,260 |
Reduced by— if no quality data are assessed: | 180 | 180 | 180 | 230 | 60 |
if no safety data are assessed: | 1,440 | 1,440 | 900 | 1,150 | 480 |
if no efficacy data are assessed: | 1,800 | 1,440 | 1,080 | 1,380 | 540 |
if no ecotoxicity data are assessed: | 120 | 120 | – | – | 60 |
Additional fee if there is more than one target species, for each additional species (non- food-producing animal): | 2,460 | 2,060 | 1,530 | 1,950 | 800 |
Reduced by— if no quality data are assessed: | 180 | 180 | 180 | 230 | 60 |
if no safety data are assessed: | 180 | 180 | 120 | 150 | 60 |
if no efficacy data are assessed: | 1,800 | 1,440 | 1,080 | 1,380 | 540 |
if no ecotoxicity data are assessed: | 60 | 60 | – | – | 60 |
Additional fee for each additional recommended route of administration(food-producing animal): | 2,650 | 2,460 | 1,590 | 2,040 | 930 |
Reduced by— if no safety data are assessed: | 1,440 | 1,440 | 900 | 1,150 | 480 |
if no efficacy data are assessed: | 900 | 720 | 540 | 690 | 300 |
if no ecotoxicity data are assessed: | 60 | 60 | – | – | 60 |
Additional fee for each additional recommended route of administration(non- food-producing animal): | 1,190 | 1,000 | 730 | 930 | 400 |
Reduced by— if no safety data are assessed: | 180 | 180 | 120 | 150 | 60 |
if no efficacy data are assessed: | 900 | 720 | 540 | 690 | 300 |
Simultaneous applications: fee for each additional product in the application: | 2,850 | 2,850 | 2,850 | 3,640 | 1,660 |
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download.
Would you like to continue?
The Whole Instrument you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
The Schedules you have selected contains over 200 provisions and might take some time to download. You may also experience some issues with your browser, such as an alert box that a script is taking a long time to run.
Would you like to continue?
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: